Status:
UNKNOWN
Zolmitriptane as Prophylaxis for Chilhood Migraine
Lead Sponsor:
Tanta University
Conditions:
Migraine
Eligibility:
All Genders
8-18 years
Phase:
PHASE4
Brief Summary
zolmitriptane can be tried as prophylactic therapy of childhood migraine
Detailed Description
90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate
Eligibility Criteria
Inclusion
- children with migraine -
Exclusion
- those who suffer from ischemic heart disease , or who have allergy to any of drugs used
- \-
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06089356
Start Date
January 1 2023
End Date
January 1 2024
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelsheikh University
Tanta, Kafrelsheikh, Egypt